Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 100878101000001113 | Elbasvir + Grazoprevir (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 100878201000001118 | Elbasvir + Grazoprevir | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Elbasvir + Grazoprevir | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier | ||
| Elbasvir + Grazoprevir | Is a | Product containing Hepatitis C virus NS3/4A protease inhibitor (product) | false | Inferred relationship | Existential restriction modifier | ||
| Elbasvir + Grazoprevir | Is a | Product containing Hepatitis C virus protein NS5A inhibitor (product) | false | Inferred relationship | Existential restriction modifier | ||
| Elbasvir + Grazoprevir | Has active ingredient | Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Elbasvir + Grazoprevir | Has active ingredient | Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Elbasvir 50mg / Grazoprevir 100mg tablets | Is a | False | Elbasvir + Grazoprevir | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR